Results 11 to 20 of about 1,199,024 (153)

Pharmacological and Pathological Implications of Sigma-1 Receptor in Neurodegenerative Diseases [PDF]

open access: yesBiomedicines
Originally identified as a potential receptor for opioids, the sigma-1 receptor is now recognized as an intracellular chaperone protein associated with mitochondria-associated membranes at the endoplasmic reticulum (ER).
Noah Drewes   +3 more
doaj   +2 more sources

Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs

open access: yesJournal of Pharmacological Sciences, 2015
Sigma-1 receptor ligands have been long expected to serve as drugs for treatment of human diseases such as neurodegenerative disorders, depression, idiopathic pain, drug abuse, and cancer.
Teruo Hayashi
doaj   +3 more sources

The sigma-1 receptor as a neurohomeostatic decision hub for GABARAP-mediated receptor trafficking and macroautophagy [PDF]

open access: yesFrontiers in Molecular Biosciences
Gamma-aminobutyric acid receptor-associated protein (GABARAP) is a multifunctional member of the autophagy-related (ATG8) protein family, playing key roles in two distinct cellular pathways: macroautophagy and plasma membrane protein trafficking.
Marius Wilhelm Baeken   +4 more
doaj   +2 more sources

Viewpoints Sigma-1 receptor agonist fluvoxamine for multiple sclerosis [PDF]

open access: yesBrain, Behavior, & Immunity - Health
Accumulating evidence suggests that the Epstein-Barr virus (EBV) plays a key role in the development of multiple sclerosis (MS). Additionally, depressive symptoms often precede the onset of MS.
Kenji Hashimoto
doaj   +2 more sources

TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death [PDF]

open access: yes, 2019
Sigma-2 receptors have been implicated in both tumor proliferation and neurodegenerative diseases. Recently the sigma-2 receptor was identified as transmembrane protein 97 (TMEM97).
Hawkins, William G.   +9 more
core   +3 more sources

3D-QSAR and docking studies of pentacycloundecylamines at the sigma-1 (σ1) receptor [PDF]

open access: yes, 2013
Pentacycloundecylamine (PCU) derived compounds have been shown to be promising lead structures for the development of novel drug candidates aimed at a variety of neurodegenerative and psychiatric diseases.
Ablordeppey   +31 more
core   +1 more source

Sigma-1 Receptor Plays a Negative Modulation on N-type Calcium Channel

open access: yesFrontiers in Pharmacology, 2017
The sigma-1 receptor is a 223 amino acids molecular chaperone with a single transmembrane domain. It is resident to eukaryotic mitochondrial-associated endoplasmic reticulum and plasma membranes.
Kang Zhang   +7 more
doaj   +1 more source

Sigma-2 Receptor—A Potential Target for Cancer/Alzheimer’s Disease Treatment via Its Regulation of Cholesterol Homeostasis

open access: yesMolecules, 2020
The sigma receptors were classified into sigma-1 and sigma-2 receptor based on their different pharmacological profiles. In the past two decades, our understanding of the biological and pharmacological properties of the sigma-1 receptor is increasing ...
Kai Yang   +5 more
doaj   +1 more source

Rapid reduction of sigma(1)-Receptor binding and F-18-FDG uptake in rat gliomas after in vivo treatment with doxorubicin [PDF]

open access: yes, 2007
sigma-Receptors are strongly overexpressed in most rodent and human tumors and are proliferation markers. To evaluate the potential of a radiolabeled sigma(1)-ligand for therapy monitoring, we compared early changes of C-11-1-(3,4-dimethoxyphenethyl)-4 ...
de Jong, Johan R.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy